The funding will support roclub’s expansion into the US and the development of a marketplace platform that connects healthcare organisations with qualified medical technologists.
The teleoperation platform for medical technology roclub, has raised $11.7 million in a Series A to fuel its next stage of growth. The round was led by Smedvig Ventures and YZR Capital, with participation from existing investor Speedinvest and angel investors.
roclub is a vendor-agnostic teleoperation platform that enables secure, remote access and control of medtech equipment, initially focused on MRI and CT, with expansion to other modalities. Its cloud- and AI-based architecture integrates with scanners from any manufacturer, allowing technologists to operate multiple machines across sites, maintain business continuity, and improve device utilisation while reducing downtime and operating costs.
By easing staffing constraints and geographic barriers, roclub helps hospitals and imaging centres deliver consistent, high-quality radiological services and broaden patient access to advanced diagnostics.
The smartphone-sized roclub connector can connect to any monitored medtech device, enabling remote access and control from anywhere and supporting direct video and audio between on-site staff, remote operators, and patients. With AI-assisted workflows, roclub helps reduce patient wait times and improve care outcomes, while giving technologists hybrid-work flexibility without requiring physical presence.
Founded in 2022 by Dr Matthias Issing and André Glardon, who previously ran a large network of diagnostic centres in Europe and experienced technologist shortages and underused equipment firsthand, roclub now operates in 11 countries, serving major hospitals and outpatient imaging providers.
Matthias Issing emphasised that the company’s goal is to establish itself as the global benchmark for teleoperation in medtech, providing seamless, secure, and intelligent remote access and control of medical devices worldwide.
By unifying medtech, robotics, AI, and ultra-low-latency connectivity, roclub aims to empower technologists and clinicians to perform complex procedures with precision and collaboration across borders, transforming access to expert care into a truly global capability.
The funding will advance AI-driven development of its teleoperation platform and a marketplace that connects healthcare organisations with remote technologists to operate connected medtech devices, helping hospitals and clinics address persistent access gaps.
Building on this momentum, roclub will enter the US market, double its headcount in 2026, and strengthen its sales and customer success functions.